AudioCure Pharma raises €9.0M Series A round

29 November 2016· Berlin, Germany· health, biopharma, biotech, b2b, deep_hardware

AudioCure used the funding to advance its lead molecule AC102 into Phase I clinical trials for the treatment of acute hearing loss and acute tinnitus.

Investors

LeadMED-EL

Also participating

High-Tech Gründerfonds

About AudioCure Pharma

Stage

Series A

Headquarters

Berlin, Germany

Founded

2012

Team Size

6–20

Sectors

healthbiopharmabiotechb2bdeep_hardware

https://audiocure.com/

Source: https://audiocure.com/2016/11/29/audiocure-completes-financing-round-with-med-el-and-htgf/